PharmaceuticalOutsourcingQ42020 - 22

AN INTERVIEW WITH...

Leandro Moreira

SVP, Marketing & Business Development,
Yourway

How would you describe Yourway's role in the life
sciences industry? What need are you filling?

individual needs. We offer true one-on-one customer service that

Yourway is a single-source packaging and supply chain partner

As importantly, our people have decades of experience in pharma-

ensures high-quality, responsive, tailored support from start to finish.

that offers a full range of services including primary and secondary

ceutical logistics and are the key to our rapid growth. They help clients

clinical packaging, temperature-controlled logistics, and storage

optimize resources and ensure adoption of the most efficient clinical

and distribution services for the global pharmaceutical and biotech

trial logistics strategies. Indeed, many virtual pharma companies turn

industries.

to Yourway to manage their entire logistics programs.

Clients enjoy the convenience of having one service provider and one

Time is of the essence in drug development and commercialization.

project manager assigned to coordinate the planning and execution

At Yourway, we always operate with the mentality that every project

of services to assist them in properly solving the operational and

is urgent, whether it is a transportation project, a clinical packing

regulatory complexities associated with each project.

Clients

project or any number of services we provide. This approach gives

appreciate the fact they can rely on Yourway's unique ability to

us the necessary agility to excel during normal conditions and

provide integrated and comprehensive services such as:

during challenging times such as the current pandemic. As a result,
Yourway has become a natural choice for clients in need of support

*	

Procurement of comparator drugs and ancillary supplies;

*	

Primary and secondary packaging;

*	

Translation services;

*	

Label and booklet printing;

today. As such, the greatest benefit Yourway provides to our customers,

*	

Qualified Person (QP) releases;

which range from small virtual biotechs to mid-size and large pharma

*	

Importer of Record (IOR) and customs brokerage services;

*	

Specialized temperature-controlled transportation and

everything is urgent is well aligned with the need to get vaccines

storage for all temperature ranges from -180°C to controlled

distributed fast and efficiently as soon as they are approved.

for various studies currently in place, including trials focusing on the
development of therapies to combat COVID-19.
Being first to the clinic and first to market is essential in the industry

companies, is shortened turnaround times. We are structured to get
materials out the door today - never tomorrow. Our mentality that

15°C to 25°C;
*	
*	

depots strategically located in all continents; and

What role will Yourway play in COVID-19
vaccine distribution?

Returns and destruction services with full accountability.

Yourway's temperature-controlled management services cover

Temperature-controlled storage at one of our 21 global GMP

storage, pick-up through delivery and include monitoring and gel pack

What is Yourway's business model? And what sets
Yourway apart from its competitors?
Unlike other players in the life sciences logistics space, Yourway offers
highly personalized services to drive efficiency through quality and
compliance. We provide integrated services such as transportation,
clinical packaging, and comparator sourcing.

Other companies

or dry ice replenishment. Our capabilities, network and experience
are paramount to the efficient distribution of vaccines becuase they
require strict temperature management and speedy deliveries. We
have vast experience handling ambient and controlled-ambient,
refrigerated (2°C to 8°C), and frozen (-20 °C to -80 °C) products using
both passive and active temperature-controlled systems.

usually provide one service or the other. We have the bandwidth of

In addition to storage and distribution, our worldwide services also

a large firm, but remain attentive and responsive to our customers'

include documentation support and the provision of regulatory

Pharmaceutical Outsourcing |

22

| October/November/December 2020



PharmaceuticalOutsourcingQ42020

Table of Contents for the Digital Edition of PharmaceuticalOutsourcingQ42020

Editor's Message
Editorial Advisory Board
CN Perspectives
Social Media Connections
Insider Insight - Price
Insider Insight - Ventura
Contract Manufacturing
Supply Chain
Contract Manufacturing
Interview with Yourway
Supply Chain
Clinical Trials
Roundtable
Supply Chain
Analytical Testing
Supply Chain
Clinical Trials
Analytical Testing
Horizon Lines
Industry News
Advertiser's Index
PharmaceuticalOutsourcingQ42020 - Cover1
PharmaceuticalOutsourcingQ42020 - Cover2
PharmaceuticalOutsourcingQ42020 - 1
PharmaceuticalOutsourcingQ42020 - Editor's Message
PharmaceuticalOutsourcingQ42020 - 3
PharmaceuticalOutsourcingQ42020 - 4
PharmaceuticalOutsourcingQ42020 - 5
PharmaceuticalOutsourcingQ42020 - Editorial Advisory Board
PharmaceuticalOutsourcingQ42020 - 7
PharmaceuticalOutsourcingQ42020 - CN Perspectives
PharmaceuticalOutsourcingQ42020 - Social Media Connections
PharmaceuticalOutsourcingQ42020 - Insider Insight - Price
PharmaceuticalOutsourcingQ42020 - 11
PharmaceuticalOutsourcingQ42020 - Insider Insight - Ventura
PharmaceuticalOutsourcingQ42020 - 13
PharmaceuticalOutsourcingQ42020 - Contract Manufacturing
PharmaceuticalOutsourcingQ42020 - 15
PharmaceuticalOutsourcingQ42020 - 16
PharmaceuticalOutsourcingQ42020 - 17
PharmaceuticalOutsourcingQ42020 - Supply Chain
PharmaceuticalOutsourcingQ42020 - 19
PharmaceuticalOutsourcingQ42020 - Contract Manufacturing
PharmaceuticalOutsourcingQ42020 - 21
PharmaceuticalOutsourcingQ42020 - Interview with Yourway
PharmaceuticalOutsourcingQ42020 - 23
PharmaceuticalOutsourcingQ42020 - Supply Chain
PharmaceuticalOutsourcingQ42020 - 25
PharmaceuticalOutsourcingQ42020 - 26
PharmaceuticalOutsourcingQ42020 - 27
PharmaceuticalOutsourcingQ42020 - 28
PharmaceuticalOutsourcingQ42020 - 29
PharmaceuticalOutsourcingQ42020 - Clinical Trials
PharmaceuticalOutsourcingQ42020 - 31
PharmaceuticalOutsourcingQ42020 - 32
PharmaceuticalOutsourcingQ42020 - Roundtable
PharmaceuticalOutsourcingQ42020 - 34
PharmaceuticalOutsourcingQ42020 - 35
PharmaceuticalOutsourcingQ42020 - Supply Chain
PharmaceuticalOutsourcingQ42020 - 37
PharmaceuticalOutsourcingQ42020 - 38
PharmaceuticalOutsourcingQ42020 - 39
PharmaceuticalOutsourcingQ42020 - Analytical Testing
PharmaceuticalOutsourcingQ42020 - 41
PharmaceuticalOutsourcingQ42020 - 42
PharmaceuticalOutsourcingQ42020 - 43
PharmaceuticalOutsourcingQ42020 - Supply Chain
PharmaceuticalOutsourcingQ42020 - 45
PharmaceuticalOutsourcingQ42020 - 46
PharmaceuticalOutsourcingQ42020 - 47
PharmaceuticalOutsourcingQ42020 - Clinical Trials
PharmaceuticalOutsourcingQ42020 - 49
PharmaceuticalOutsourcingQ42020 - 50
PharmaceuticalOutsourcingQ42020 - Analytical Testing
PharmaceuticalOutsourcingQ42020 - 52
PharmaceuticalOutsourcingQ42020 - 53
PharmaceuticalOutsourcingQ42020 - Horizon Lines
PharmaceuticalOutsourcingQ42020 - 55
PharmaceuticalOutsourcingQ42020 - 56
PharmaceuticalOutsourcingQ42020 - 57
PharmaceuticalOutsourcingQ42020 - Industry News
PharmaceuticalOutsourcingQ42020 - 59
PharmaceuticalOutsourcingQ42020 - 60
PharmaceuticalOutsourcingQ42020 - 61
PharmaceuticalOutsourcingQ42020 - 62
PharmaceuticalOutsourcingQ42020 - 63
PharmaceuticalOutsourcingQ42020 - Advertiser's Index
PharmaceuticalOutsourcingQ42020 - Cover3
PharmaceuticalOutsourcingQ42020 - Cover4
https://www.nxtbook.com/comparenetworks/PharmaceuticalOutsourcing/po-q2-2021
https://www.nxtbook.com/comparenetworks/PharmaceuticalOutsourcing/PharmaceuticalOutsourcing2021CompanyFocus
https://www.nxtbook.com/comparenetworks/PharmaceuticalOutsourcing/PharmaceuticalOutsourcingQ42020
https://www.nxtbookmedia.com